A detailed history of Pya Waltman Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pya Waltman Capital, LLC holds 18,051 shares of ABBV stock, worth $3.17 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
18,051
Previous 17,205 4.92%
Holding current value
$3.17 Million
Previous $2.95 Million 20.77%
% of portfolio
1.32%
Previous 1.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $138,608 - $168,633
846 Added 4.92%
18,051 $3.56 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $172,900 - $201,908
1,117 Added 6.94%
17,205 $2.95 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $45,069 - $51,352
282 Added 1.78%
16,088 $2.93 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $266,806 - $300,486
1,939 Added 13.98%
15,806 $2.45 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $414,930 - $480,342
3,106 Added 28.86%
13,867 $2.07 Million
Q2 2023

Aug 15, 2023

BUY
$132.51 - $164.9 $380,171 - $473,098
2,869 Added 36.35%
10,761 $1.45 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $354,872 - $408,689
2,454 Added 45.13%
7,892 $1.26 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $129,181 - $154,922
934 Added 20.74%
5,438 $879,000
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $343,040 - $393,445
2,556 Added 131.21%
4,504 $604,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $88,902 - $113,024
646 Added 49.62%
1,948 $298,000
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $72,589 - $90,062
550 Added 73.14%
1,302 $211,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $80,787 - $102,219
752 New
752 $102,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pya Waltman Capital, LLC Portfolio

Follow Pya Waltman Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pya Waltman Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pya Waltman Capital, LLC with notifications on news.